Capricor Therapeutics: Funding, Investors & Team (Oct 2026)
Capricor Therapeutics is a biotechnology company that specializes in creating and bringing to market cell and exosome-based therapeutics for fighting diseases. They are currently working on CAP-1002, a cell therapy option for Duchenne muscular dystrophy and COVID-19. The company was established in 2005 and is based in Los Angeles, California.
Capricor Therapeutics has raised $165M across 2 funding rounds on record, the most recent an undisclosed round of $150M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Capricor Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Capricor Therapeutics Funding Rounds
Capricor Therapeutics raised $15.0M in an undisclosed round announced in Sep 2024.
1.3 years later, an undisclosed round of $150M was announced in Dec 2025.
Capricor Therapeutics Founders and Leadership Team
Contact details for the Capricor Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Capricor Therapeutics Funding Compared to Other Biotechnology Startups
Capricor Therapeutics' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Capricor Therapeutics in Biotechnology and Los Angeles
Companies Similar to Capricor Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Capricor Therapeutics Funding FAQs
What does Capricor Therapeutics do?
Capricor Therapeutics is a biotechnology company that specializes in creating and bringing to market cell and exosome-based therapeutics for fighting diseases. They are currently working on CAP-1002, a cell therapy option for Duchenne muscular dystrophy and COVID-19. The company was established in 2005 and is based in Los Angeles, California.
How much funding has Capricor Therapeutics raised?
Capricor Therapeutics has raised $165M across 2 rounds on record. The most recent is an undisclosed round of $150M announced in Dec 2025.
When did Capricor Therapeutics last raise funding?
Capricor Therapeutics' most recent funding round on record is an undisclosed round of $150M, announced in Dec 2025.
Who founded Capricor Therapeutics?
FundedIQ lists Linda Marban (Founder) at Capricor Therapeutics.
Where is Capricor Therapeutics headquartered?
Capricor Therapeutics is based in Los Angeles, California, United States.
How many employees does Capricor Therapeutics have?
Capricor Therapeutics is in the 101-250 employee band.
How does Capricor Therapeutics' funding compare to other Biotechnology startups?
Capricor Therapeutics' latest round of $150M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Capricor Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Capricor Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.